Baku 3° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
15:24
Photo
Azerbaijan, Malaysia discuss cooperation in emergency management
Domestic policy15:22
Photo
President Ilham Aliyev arrives in Switzerland to attend World Economic Forum annual meeting
Foreign policy15:12
Azerbaijan's state budget surplus surpassed $310M in 2025
Finance15:00
Azerbaijan posts 1% increase in gas extraction in 2025
Energy14:58
Nominal income of Azerbaijan's population rises by 8%
Finance14:45
ANAMA: Over 500 hectares of land cleared of mines last week
Domestic policy14:36
Azerbaijan's population exceeds 10.2 million
Social security14:34
Iran President Pezeshkian urges swift removal of internet restrictions
Other countries14:25